Co-Diagnostics, Inc. to Host Booth at MEDEXPO Africa 2022 in Nairobi, Kenya on June 9-11

Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq: CODX) is participating in the 22nd MEDEXPO Africa 2022 in Nairobi, Kenya from June 9-11. This significant event showcases over 30 countries' medical technology solutions, aiming at buyers seeking innovative products and services. This marks Co-Dx's first trade show in Africa, enhancing its initiative to promote COVID-19 and other infectious disease tests across the continent. Notably, the company has completed the design of a PCR test for monkeypox. Interested attendees can find Co-Dx at Booth #124.

SALT LAKE CITY, June 9, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the 22^nd MEDEXPO Africa 2022, held June 9-11 in Nairobi, Kenya.

The largest international medical trade exhibition in the country features exhibitors from over 30 countries, all profiling innovative solutions from leaders in the medical technology industry, and targeted toward buyers from across the continent seeking new products, equipment, machinery, services and solutions. The conference represents the Company's first trade show in Africa, and is expected to build on an initiative that began nearly a year ago to introduce Co-Dx products across the continent, including its suite of tests for COVID-19 and other infectious diseases. The Company recently announced that it had completed the principal design work of a PCR test for the monkeypox virus currently exhibiting a multi-country outbreak.

Attendees interested in learning more about the Company and its products are invited to visit Booth #124 at the Sarit Expo Centre.

About Co-Diagnostics, Inc.:

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medexpo-africa-2022-in-nairobi-kenya-on-june-9-11-301564864.html

SOURCE Co-Diagnostics

FAQ

What is the significance of Co-Diagnostics' participation in MEDEXPO Africa 2022?

Co-Diagnostics is showcasing its diagnostic solutions at MEDEXPO Africa 2022, aiming to introduce its products to the African market.

When is MEDEXPO Africa 2022 taking place?

MEDEXPO Africa 2022 is held from June 9-11, 2022.

Where can attendees find Co-Diagnostics at the event?

Attendees can visit Co-Diagnostics at Booth #124 at the Sarit Expo Centre.

What products is Co-Diagnostics promoting at MEDEXPO Africa 2022?

Co-Diagnostics is promoting its suite of tests for COVID-19 and other infectious diseases.

Has Co-Diagnostics developed any new tests recently?

Yes, Co-Diagnostics recently completed the design of a PCR test for monkeypox.